Nurse Practitioner, Family · Lansing, MI
NPI
1487729752
Since 2006
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4333 W St Joe Hwy
Lansing, MI, 48917
Phone (517) 321-1525
Groups this clinician bills Medicare through
Medicare paid, 2024
$850K
62,210 services
Medicare patients, 2024
213
Average age 66
Drug cost, 2024
$9.0M
3,544 prescriptions
Company payments, 2025
$7,094
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Iris Zink was code J3111 (injection, romosozumab-aqqg, 1 mg), 16,590 times for 12 patients. In total Iris Zink billed 62,210 services in 35 codes, and Medicare paid $850K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 16,590 | 12 | $8.49 | $141K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 13,150 | 16 | $8.67 | $114K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 12,200 | 21 | $33.85 | $413K |
| J0897 Injection, denosumab, 1 mg | Office | 3,841 | 39 | $20.55 | $79K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,180 | 14 | $0.10 | $116 |
| 96372 Injection Administration | Office | 297 | 57 | $8.91 | $2,646 |
| 96365 Intravenous Infusion, Hydration | Office | 255 | 48 | $38.01 | $9,693 |
| 99214 Office E&M - Established | Office | 253 | 145 | $67.94 | $17K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 126 | 17 | $0.51 | $64.18 |
| 77080 Standard X-ray | Office | 35 | 35 | $29.32 | $1,026 |
| 99215 Office E&M - Established | Office | 29 | 26 | $95.11 | $2,758 |
| 99204 Office E&M - New | Office | 18 | 18 | $79.58 | $1,432 |
| 77085 Standard X-ray | Office | 15 | 15 | $41.38 | $621 |
By year: 2022 $745K for 41,218 services; 2023 $806K for 53,567 services; 2024 $850K for 62,210 services.
Medicare prescription drug claims, 2024
In 2024, the drug Iris Zink prescribed most often to Medicare patients was Prednisone, with 266 prescriptions and refills. In total Iris Zink wrote 3,544 Medicare prescriptions that cost $9.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 266 | 488 | 101 | $2,919 |
| Humira(Cf) Pen Adalimumab | 239 | 244 | 39 | $2.0M |
| Allopurinol Generic | 196 | 517 | 74 | $3,017 |
| Methotrexate Methotrexate Sodium | 185 | 300 | 47 | $7,442 |
| Levothyroxine Sodium Generic | 160 | 429 | 51 | $1,960 |
| Hydroxychloroquine Sulfate Generic | 144 | 342 | 56 | $9,021 |
| Leflunomide Generic | 116 | 264 | 44 | $7,047 |
| Rinvoq Upadacitinib | 108 | 108 | 24 | $673K |
| Orencia Clickject Abatacept | 102 | 104 | 18 | $585K |
| Tramadol Hcl Generic | 98 | 105 | 20 | $870 |
| Enbrel Sureclick Etanercept | 89 | 89 | 22 | $641K |
| Alendronate Sodium Generic | 80 | 119 | 25 | $436 |
| Duloxetine Hcl Generic | 65 | 165 | 21 | $2,617 |
| Cosentyx Sensoready Pen Secukinumab | 62 | 62 | 12 | $578K |
| Gabapentin Generic | 60 | 103 | 19 | $828 |
Brand drugs: 1,389 claims; generic drugs: 2,134 claims; opioid claims: 126.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Iris Zink $7,094 ($7,094 in general payments such as food, travel and fees) from 21 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $1,936.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 19 | $1,936 |
| Janssen Biotech, Inc. JNJ | 48 | $1,310 |
| Amgen Inc. AMGN | 29 | $719 |
| Abbvie Inc. ABBV | 43 | $696 |
| UCB, Inc. UCB.BR | 23 | $607 |
| Novartis Pharmaceuticals Corporation NVS | 18 | $464 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $384 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $177 |
| Organon LLC OGN | 6 | $131 |
| LEO Pharma Inc. | 2 | $122 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.